GOLGA7
Golgin subfamily A member 7
Also known as: GCP16, GOGA7_HUMAN, GOLGA3AP1, GOLGA7A, HSPC041
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q7Z5G4
- Gene
- GOLGA7
- Ensembl
- ENSG00000147533
- Chromosome
- 8
- Canonical length
- 137 aa
- Protein class
- Predicted intracellular proteins, Transporters
OverviewNCBI Gene
Involved in Golgi to plasma membrane protein transport; peptidyl-L-cysteine S-palmitoylation; and protein stabilization. Acts upstream of or within Golgi to plasma membrane transport. Located in Golgi membrane and Golgi stack. Part of palmitoyltransferase complex. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
137 residues, UniProt reviewed canonical sequence.
>Q7Z5G4|GOLGA7
1 MRPQQAPVSG KVFIQRDYSS GTRCQFQTKF PAELENRIDR QQFEETVRTL NNLYAEAEKL
61 GGQSYLEGCL ACLTAYTIFL CMETHYEKVL KKVSKYIQEQ NEKIYAPQGL LLTDPIERGL
121 RVIEITIYED RGMSSGRLocalizationUniProt · AlphaFold · HPA
Whether an antibody against GOLGA7 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Other membrane
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.35
- Highest tissue expression
- 104 nTPM
Expression across tissuesHPA
Tissue
- spinal cord: 104 nTPM
- midbrain: 93 nTPM
- amygdala: 82 nTPM
- hippocampal formation: 82 nTPM
- basal ganglia: 81 nTPM
- hypothalamus: 58 nTPM
Single-cell type
- oocytes: 304 nCPM
- neutrophils: 296 nCPM
- early primary spermatocytes: 188 nCPM
- differentiating spermatogonia: 139 nCPM
- esophageal apical cells: 122 nCPM
- syncytiotrophoblasts: 113 nCPM
Immune cell
- basophil: 285 nTPM
- total PBMC: 201 nTPM
- neutrophil: 190 nTPM
- T-reg: 144 nTPM
- gdT-cell: 120 nTPM
- classical monocyte: 120 nTPM
Brain region
- white matter: 181 nTPM
- basal ganglia: 151 nTPM
- medulla oblongata: 129 nTPM
- midbrain: 123 nTPM
- cerebral cortex: 118 nTPM
- thalamus: 115 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.63
- gnomAD pLI
- 0.46
- gnomAD missense Z
- 1.45
- DepMap mean gene effect
- 0.01
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 10% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- Golgi to plasma membrane protein transport
- Golgi to plasma membrane transport
- post-translational protein modification
- protein targeting to membrane
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of GOLGA7 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads GOLGA7 as an antibody target. Whether an autoantibody or antibody against GOLGA7 could matter depends on whether native GOLGA7 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
GOLGA7 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label GOLGA7 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...